Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort.
about
Alanine-glyoxylate aminotransferase 2 (AGXT2) polymorphisms have considerable impact on methylarginine and β-aminoisobutyrate metabolism in healthy volunteersTranssulfuration pathway thiols and methylated arginines: the Hunter Community StudySymmetric dimethylarginine as predictor of graft loss and all-cause mortality in renal transplant recipientsAsymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective StudiesIncreased Symmetric Dimethylarginine Level Is Associated with Worse Hospital Outcomes through Altered Left Ventricular Ejection Fraction in Patients with Acute Myocardial Infarction.Comparison of serum concentrations of symmetric dimethylarginine and creatinine as kidney function biomarkers in cats with chronic kidney disease.Renal biomarkers in domestic species.Effects of chronic SDMA infusion on glomerular filtration rate, blood pressure, myocardial function and renal histology in C57BL6/J mice.Nitric oxide synthesis capacity, ambulatory blood pressure and end organ damage in a black and white population: the SABPA study.Long-Term Intermittent Work at High Altitude: Right Heart Functional and Morphological Status and Associated Cardiometabolic Factors.Diagnostic value of plasma tryptophan and symmetric dimethylarginine levels for acute kidney injury among tacrolimus-treated kidney transplant patients by targeted metabolomics analysis
P2860
Q24338511-8C49C1A2-0235-4B93-912D-5EE4C526A1A2Q28485286-4C1D8468-E0B6-403C-A2D5-F019DCCE23D9Q34556614-5AAD5CCE-D8F6-4E70-8B86-BADE6904F91DQ36182184-971E35BF-0BBC-408A-997E-454FA2A734B2Q36260985-66A0A6BE-1D43-4D4C-848C-AD4937871A6BQ36975461-6640B109-B811-4AA4-A2F9-181B06788722Q38751246-2A4F5F36-76A5-488C-9AED-8326E2DFD509Q39491072-85F60BAB-5F08-4625-AB96-A69FC640431DQ41120288-13092A2D-941C-4FA6-9FD9-5313902FDCEBQ52603648-58DFB066-D86E-46AA-B9CD-B9F9D4393FAEQ57050360-D915238D-90E1-4212-AED3-97406229B8A2
P2860
Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort.
@ast
Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort.
@en
type
label
Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort.
@ast
Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort.
@en
prefLabel
Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort.
@ast
Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort.
@en
P2093
P2860
P50
P356
P1476
Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort.
@en
P2093
Dorothee Atzler
Edzard Schwedhelm
Nicole L Glazer
Nicole Lüneburg
Rainer H Böger
Renke Maas
Ulrich Riederer
P2860
P304
P356
10.1515/CCLM.2011.679
P577
2011-08-25T00:00:00Z